Ophthavet Ophthalmic Solution, 0.18% Viscoadaptive Sodium Hyaluronate

Recall announced April 30, 2026 by Dechra Veterinary Products Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Lack of sterility assurance because of a potential quality concern at the manufacturing site. It affects dogs and cats. The agency has not closed this recall.

Brands
Ophthavet
Where sold
US Nationwide.
Last updated
November 13, 2026

Products included

Read the official notice. Always compare the codes on your package with the official notice. It is the final word.

Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.

See all pet recalls